Product Information
LABETALOL HCL 300 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.2086 per EA under NDC 72888012201. Its NADAC has been published 229 times since Feb 9, 2022.
Strength
300 mg/1
Manufacturer
Advagen Pharma Ltd.NDC
72888012201
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LABETALOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211953On Market Since
8/18/2021
Pharmacological Classes
Price Statistics
The NADAC for LABETALOL HCL 300 MG TABLET has been published 229 times since Feb 9, 2022, and over the history we have for it it has risen 3.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2086 per EA |
|---|---|
| All-time high | $0.2383 (Aug 10, 2022) |
| All-time low | $0.1776 (Nov 20, 2024) |
| 52-week high | $0.2117 |
| 52-week low | $0.1998 |
| Median price | $0.2092 |
| Average price | $0.2097 |
| Largest weekly change | -16.9% (Jul 17, 2024) |
| Weeks tracked | 229 |
| Tracking since | Feb 9, 2022 |
Generic Alternatives
The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LABETALOL HCL 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 300 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.2086 per EA (NDC 72888012201), effective Jun 24, 2026.
How has the price of LABETALOL HCL 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for LABETALOL HCL 300 MG TABLET has risen 3.3%. It has been tracked across 229 weekly CMS publications since Feb 9, 2022.
What are the highest and lowest recorded NADAC prices for LABETALOL HCL 300 MG TABLET?
Since Feb 9, 2022, the NADAC for LABETALOL HCL 300 MG TABLET has ranged from a low of $0.1776 (Nov 20, 2024) to a high of $0.2383 (Aug 10, 2022), with a median of $0.2092 per EA.
Are there cheaper alternatives to LABETALOL HCL 300 MG TABLET?
Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LABETALOL HCL 300 MG TABLET, is $0.2041 per EA — about 2% below LABETALOL HCL 300 MG TABLET.
Who manufactures LABETALOL HCL 300 MG TABLET?
LABETALOL HCL 300 MG TABLET (NDC 72888012201) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.
Related Drugs
Same classification